Myocardial energetics and cardiac function of preserved rat heart.

Myocardial energetics and ubiquinol in diastolic heart failure.

$Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.$
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.

Cardiac energetics.

$Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.$
Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.

Early postnatal rat ventricle resection leads to long-term preserved cardiac function despite tissue hypoperfusion.

DPP4 deficiency preserved cardiac function in abdominal aortic banding rats.

Preserved atrial natriuretic peptide secretory function after cardiac transplantation.

ICD role in preventing sudden cardiac death in Emery-Dreifuss muscular dystrophy with preserved myocardial function: 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy.

Changes in heart function and cardiac cell size in rats with chronic myocardial infarction.

Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart.

Alterations in cardiac structure and function in a modified rat model of myocardial hypertrophy.

Myocardial energetics and the role of micronutrients in heart failure: a critical review.

Effects of human atrial natriuretic peptide on myocardial performance and energetics in heart failure due to previous myocardial infarction.

Effects of LDL and oxidized LDL on cardiac function in isoproterenol-induced myocardial infarction in rat.

Load and length regulation of cardiac energetics.

Species differences in cardiac energetics.

Age-associated alterations of cardiac structure and function in the female F344xBN rat heart.

Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment.

Molecule specific effects of PKA-mediated phosphorylation on rat isolated heart and cardiac myofibrillar function.

Effect of anesthesia on cardiac function and response in the perfused rat heart.

Cardiac resynchronization therapy plus coupled pacing improves acutely myocardial function in heart failure patients.

Smooth muscle cell sheet transplantation preserve cardiac function and minimize cardiac remodeling in a rat myocardial infarction model.

$Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.$
Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.

$Myocardial hypertrophy and its role in heart failure with preserved ejection fraction.$
Myocardial hypertrophy and its role in heart failure with preserved ejection fraction.

Suggest Documents

Myocardial energetics and ubiquinol in diastolic heart failure.

Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.

Cardiac energetics.

Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.

Early postnatal rat ventricle resection leads to long-term preserved cardiac function despite tissue hypoperfusion.

DPP4 deficiency preserved cardiac function in abdominal aortic banding rats.

Preserved atrial natriuretic peptide secretory function after cardiac transplantation.

ICD role in preventing sudden cardiac death in Emery-Dreifuss muscular dystrophy with preserved myocardial function: 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy.

Changes in heart function and cardiac cell size in rats with chronic myocardial infarction.

Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart.

Alterations in cardiac structure and function in a modified rat model of myocardial hypertrophy.

Myocardial energetics and the role of micronutrients in heart failure: a critical review.

Effects of human atrial natriuretic peptide on myocardial performance and energetics in heart failure due to previous myocardial infarction.

Effects of LDL and oxidized LDL on cardiac function in isoproterenol-induced myocardial infarction in rat.

Load and length regulation of cardiac energetics.

Species differences in cardiac energetics.

Age-associated alterations of cardiac structure and function in the female F344xBN rat heart.

Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment.

Molecule specific effects of PKA-mediated phosphorylation on rat isolated heart and cardiac myofibrillar function.

Effect of anesthesia on cardiac function and response in the perfused rat heart.

Cardiac resynchronization therapy plus coupled pacing improves acutely myocardial function in heart failure patients.

Smooth muscle cell sheet transplantation preserve cardiac function and minimize cardiac remodeling in a rat myocardial infarction model.

Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.

Myocardial hypertrophy and its role in heart failure with preserved ejection fraction.

Myocardial energetics and cardiac function of preserved rat heart.

Recommend Documents

Follow Us